Ohio joins Indiana and Kentucky in funding Pear Therapeutics ’ digital addiction treatments

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction (pharmaforum): The company has been pushing for more reimbursement of its three marketed DTx products in the US following a first FDA approval in 2017. Pear said that the Ohio Department of Mental Health and Addiction Services (OhioMHAS) and RecoveryOhio are providing access to Pear’s FDA-approved DTx reSET and reSET‑O, for treatment of substance use disorder and opioid use disorders, respectively. Funding is provided by the State Opioid Response (SOR) 2.0 grant, administered by OhioMHAS, and part of the US Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) SOR grant programme for people in need of prevention, treatment and recovery support for opioid use disorder. The Announcement: Pear Announces Ohio Department of Mental Health and Addiction Services will Provide Access to Prescription Digital Therapeutics to Help Local Communities Continue Fight Against Opioid Addiction (press release): Pear Therapeutics, Inc. announced today that the Ohio Department of Mental Health and Addiction Services (OhioMHAS) and RecoveryOhio are providing access to Pear’s FDA-authorized prescription digital therapeutics (PDTs) reSET® and reSET‑O® for the treatment of substance use disorder (SUD) and opioid use disorder (OUD), respectively. Eligible patients will be prescribed and treated with reSET or reSET‑O to help communities throughout Ohio contin...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Brain/ Mental Health Technology & Innovation addiction cognitive-behavioral-therapy digital therapeutics FDA Indiana Kentucky Ohio opioid use disorder Pear Therapeutics prescription digital therapeutics reSET reSET-O substance Source Type: blogs